As Robert F. Kennedy Jr.’s revamped Centers for Disease Control and Prevention (CDC) vaccine advisory panel gears up to meet ...

FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...

James Potter, the executive director at Coalition for Healthcare Communication (CHC), has rose-colored glasses on. | In a ...

The resulting report, published this week ahead of Swoop’s presentation at the Fierce Pharma Week conference in Philadelphia, ...

It was another swing and a miss for the biopharma industry on Thursday, when a federal appeals court in Philadelphia ...

With Pfizer discontinuing Beqvez and BioMarin scaling back the commercial focus of Roctavian, the curative promise of ...

While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV business, the company this week triumphed over a whistleblower lawsuit | A ...